Analysts Set National Health Investors Inc (NHI) Price Target at $78.20

Shares of National Health Investors Inc (NYSE:NHI) have earned an average rating of “Hold” from the nine brokerages that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $78.20.

Several equities analysts have commented on the company. Zacks Investment Research downgraded National Health Investors from a “hold” rating to a “sell” rating in a report on Tuesday. SunTrust Banks increased their price target on National Health Investors to $85.00 and gave the company a “neutral” rating in a report on Wednesday, February 20th. They noted that the move was a valuation call. BMO Capital Markets downgraded National Health Investors from a “market perform” rating to an “underperform” rating and set a $78.00 price target on the stock. in a report on Wednesday, February 20th. KeyCorp set a $65.00 price target on National Health Investors and gave the company a “sell” rating in a report on Thursday, December 20th. Finally, ValuEngine upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Tuesday, December 11th.

NYSE:NHI opened at $79.24 on Friday. National Health Investors has a 52 week low of $65.10 and a 52 week high of $84.57. The company has a market capitalization of $3.37 billion, a P/E ratio of 14.46 and a beta of 0.51. The company has a debt-to-equity ratio of 0.92, a quick ratio of 17.92 and a current ratio of 17.92.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Tuesday, February 19th. The real estate investment trust reported $0.87 EPS for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.52). National Health Investors had a return on equity of 11.36% and a net margin of 52.38%. The firm had revenue of $74.00 million during the quarter, compared to analyst estimates of $75.16 million. During the same quarter in the prior year, the company posted $1.35 EPS. The company’s quarterly revenue was up 4.1% on a year-over-year basis. On average, sell-side analysts anticipate that National Health Investors will post 5.5 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, March 29th will be given a $1.05 dividend. This represents a $4.20 annualized dividend and a dividend yield of 5.30%. This is a boost from National Health Investors’s previous quarterly dividend of $1.00. The ex-dividend date is Thursday, March 28th. National Health Investors’s dividend payout ratio is currently 72.99%.

In other news, Director Robert A. Mccabe, Jr. sold 1,181 shares of the stock in a transaction that occurred on Thursday, February 21st. The stock was sold at an average price of $78.04, for a total value of $92,165.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 5.63% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of National Health Investors by 1.2% in the third quarter. Vanguard Group Inc. now owns 6,382,904 shares of the real estate investment trust’s stock valued at $482,484,000 after acquiring an additional 76,209 shares during the period. Vanguard Group Inc boosted its position in shares of National Health Investors by 1.2% in the third quarter. Vanguard Group Inc now owns 6,382,904 shares of the real estate investment trust’s stock valued at $482,484,000 after acquiring an additional 76,209 shares during the period. BlackRock Inc. boosted its position in shares of National Health Investors by 1.7% in the fourth quarter. BlackRock Inc. now owns 4,216,426 shares of the real estate investment trust’s stock valued at $318,508,000 after acquiring an additional 71,399 shares during the period. Lasalle Investment Management Securities LLC bought a new stake in shares of National Health Investors in the fourth quarter valued at approximately $57,125,000. Finally, Dimensional Fund Advisors LP lifted its position in National Health Investors by 2.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 659,882 shares of the real estate investment trust’s stock worth $49,847,000 after purchasing an additional 14,805 shares during the period. 70.77% of the stock is owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Liquidity

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.